Discover B2B leads for Biotechnology industry
Identify and research relevant prospects for B2B lead generation on Biotechnology sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 391 in our database
Found 2168 in our records

HQ: North Chicago, Illinois, United States
AbbVie is a pharmaceutical company that discovers,Show more... develops, and markets medicines.
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
Main email format: sarah.smith@abbvie.com (59.3%)
-
Richard A Gonzalez
r**************z@abbvie.com
-
Jonathan Pound
Sr Specialty Representative
j************d@abbvie.com
-
Andrew Dillard
a************d@abbvie.com
-
Jennifer Langan
j*************n@abbvie.com
-
Jay Stamatis
j**********s@abbvie.com
-
Miki Mancine
m**********e@abbvie.com
-
Catherine Desjardins
Regional Manager, Market Access and Government Affairs in Oncology
c******************s@abbvie.com
-
Felix J Gonzalezreyes
f*****************s@abbvie.com
-
Ateet Shah
a********h@abbvie.com
-
Robert Michael
President and Chief Operating Officer
r****t@abbvie.com
-
Tim Hale
t******e@abbvie.com
-
Kumar Kantheti
Head of Customer Insights at Regeneron Pharmaceuticals, Inc.
k************i@abbvie.com
-
Alfonso Savoia
a************a@abbvie.com
-
Marie-Charlotte GOFF
m*******************f@abbvie.com
-
Carrie Strom
Senior Vice President, US Medical Aesthetics
c**********m@abbvie.com
-
Glen Curran
Vice President, Marketing, US Eyecare
g*********n@abbvie.com
-
Jessica Campagna
Director, Regulatory Affairs
j**************a@abbvie.com
-
Natalie Anderten
Director, Clinical Development Operations
n**************n@abbvie.com
-
Gamal Ferrer
Supply Planning Manager
g**********r@abbvie.com
-
Alex Selsky
a*********y@abbvie.com
-
Bill Pappano
b**********o@abbvie.com
-
Laurence Pierard
l**************d@abbvie.com
-
Jane Woo
j******o@abbvie.com
-
Liz Lloyd
l*******d@abbvie.com
-
Francescaeugenia Civardi
f**********************i@abbvie.com
-
Eric Nelson
e*********n@abbvie.com
-
Hanne Vanspaendonk
h****************k@abbvie.com
-
Jacob Degner
j**********r@abbvie.com
-
Nestor Ortiz
n**********z@abbvie.com
-
Philip Mcquain
p************n@abbvie.com
-
Tamar Uziel
t*********l@abbvie.com
-
Jill Hoeger
j*********r@abbvie.com
-
Ahmed Othman
a**********n@abbvie.com
-
Earle Bain
e********n@abbvie.com
-
Lisa Greenstein
l*************n@abbvie.com
-
Samrat Mukherjee
s**************e@abbvie.com
-
Lloyd Lam
l*******m@abbvie.com
-
Joshua Plotnik
j************k@abbvie.com
-
Stephen Fortino
s*************o@abbvie.com
-
Robert A Love
r***********e@abbvie.com
-
Tino Seidel
t*********l@abbvie.com
-
John Engelhardt
j*************t@abbvie.com
-
Mk Steel
m******l@abbvie.com
-
Carlos Taveras
c************s@abbvie.com
-
Jens Herrfurth
j************h@abbvie.com
-
Carola Vogt
c*********t@abbvie.com
-
Ariel Ting
a********g@abbvie.com
-
Anja Moeller
a**********r@abbvie.com
-
Scott Filarski
s************i@abbvie.com
-
Joachim Vogt
j**********t@abbvie.com
-
Josue Samayoa
j***********a@abbvie.com
-
Krystal Loewe
k***********e@abbvie.com
-
Jan Lohne
j*******e@abbvie.com
-
Bei Chen
b******n@abbvie.com
-
Francesca Marrani
f***************i@abbvie.com
-
Silvija Vaitkiene
s***************e@abbvie.com
-
Thorsten Pflanzner
t****************r@abbvie.com
-
Sara Orndoff
s**********f@abbvie.com
-
Antonis Papasolomontos
a********************s@abbvie.com
-
Philipp Huwe
p**********e@abbvie.com
-
Krystal Bruno
k***********o@abbvie.com
-
Lisa Miller
l*********r@abbvie.com
-
Erica Gruvberg
e************g@abbvie.com
-
Lavina Harjani
l************i@abbvie.com
-
Andrew D Vogt
a***********t@abbvie.com
-
Meri Oliva
m********a@abbvie.com
-
Mariadelcarmen Estrada
m********************a@abbvie.com
-
Elena Dianova
e***********a@abbvie.com
-
Dawn George
d*********e@abbvie.com
-
Kent Pearson
k**********n@abbvie.com
-
Kei Takatsu
k*********u@abbvie.com
-
Johannes Huelsenbeck
j******************k@abbvie.com
-
Shunya Urata
s**********a@abbvie.com
-
Sebastian Koob
s************b@abbvie.com
-
Paul E Kroeger
p************r@abbvie.com
-
Be Mnp
b****p@abbvie.com
-
Christopher Kwok
c**************k@abbvie.com
-
Brendan Mccarthysinclair
b**********************r@abbvie.com
-
Margaret Fettiskoenders
m*********************s@abbvie.com
-
Pv Saudiarabia
p************a@abbvie.com
-
Carleigh Kmetz
c************z@abbvie.com
-
Ed Reilly
e*******y@abbvie.com
-
Cyril Ramathal
c************l@abbvie.com
-
Xin X Lu
x******u@abbvie.com
-
Adrian Hobson
a***********n@abbvie.com
-
Jason Holbert
j***********t@abbvie.com
-
Susan Bale
s********e@abbvie.com
-
Cynthia Waseity
c*************y@abbvie.com
-
Michal Roszkowski
m***************i@abbvie.com
-
Mike Dennis
m*********s@abbvie.com
-
Robert Grundman
r*************n@abbvie.com
-
Sebastian Wachtarz
s****************z@abbvie.com
-
Michael R Robinson
m****************n@abbvie.com
-
Mansour Dughbaj
m*************j@abbvie.com
-
Yixin Fang
y********g@abbvie.com
-
Lisa Hazelwood
l************d@abbvie.com
-
Hannah Palac
h**********c@abbvie.com
-
Yu Deng
y*****g@abbvie.com
-
Elizabeth Shea
e************a@abbvie.com
-
Sarah Beck
s********k@abbvie.com
-
Natalie Bennett
n*************t@abbvie.com
-
Cheryl Pitcher
c************r@abbvie.com
-
Joanna Jones
j**********s@abbvie.com
-
Nancy Sever
n*********r@abbvie.com
-
Kim Hogan
k*******n@abbvie.com
-
David Maag
d********g@abbvie.com
-
Hetal Sarvaiya
h************a@abbvie.com
-
Yuki Koshi
y********i@abbvie.com
-
Stevan W Djuric
s*************c@abbvie.com
-
Hiroki Matsuo
h***********o@abbvie.com
-
Martha Titler
m***********r@abbvie.com
-
Alexandra Smith
a*************h@abbvie.com
-
Lauren Himmel
l***********l@abbvie.com
-
Forrest Weghorst
f**************t@abbvie.com
-
Nakesha Spellman
n**************n@abbvie.com
-
Parul Singh
p*********h@abbvie.com
-
Isheeta Shah
i**********h@abbvie.com
-
Christian Sanandres
c*****************s@abbvie.com
-
Anil Vasudevan
a************n@abbvie.com
-
Justin Rayyan
j***********n@abbvie.com
-
James Marek
j*********k@abbvie.com
-
Sophee Blanthornhazell
s********************l@abbvie.com
-
Rahul Mehta
r*********a@abbvie.com
-
Javier Leaniz
j***********z@abbvie.com
-
Jit Bhowmick
j**********k@abbvie.com
-
David Masica
d**********a@abbvie.com
-
Robert Mclaughlin
r***************n@abbvie.com
-
Anuj Verma
a********a@abbvie.com
-
Jianzhen Chan
j***********n@abbvie.com
-
Stephanie Weinstein
s*****************n@abbvie.com
-
Brian C Anderson
b**************n@abbvie.com
-
Karol Charkiewicz
k***************z@abbvie.com
-
Shawn Jeffries
s************s@abbvie.com
-
Stacy Sullivan
s************n@abbvie.com
-
Geoff Gz Zhang
g************g@abbvie.com
-
Namita Tundia
n***********a@abbvie.com
-
Sarah Doupe
s*********e@abbvie.com
-
Chris Medina
c**********a@abbvie.com
-
Takafumi Tanaka
t*************a@abbvie.com
-
Razaq Salau
r*********u@abbvie.com
-
Chelsea Parrocha
c**************a@abbvie.com
-
Jane Qian
j*******n@abbvie.com
-
Bryan Rogers
b**********s@abbvie.com
-
Michael Kaltschmidt
m*****************t@abbvie.com
-
Jeroen Schrevens
j**************s@abbvie.com
-
Jamie Chouinard
j*************d@abbvie.com
-
Jeffrey Waite
j***********e@abbvie.com
-
Jason Hart
j********t@abbvie.com
-
Jules Holland
j***********d@abbvie.com
-
Melvin Munsaka
m************a@abbvie.com
-
Namjin Chung
n**********g@abbvie.com
-
Ning Sun
n******n@abbvie.com
-
Edward Ronan
e**********n@abbvie.com
-
Niharika Chauhan
n**************n@abbvie.com
-
Lin Zhu
l*****u@abbvie.com
-
Anna Levi
a*******i@abbvie.com
-
Giuliana Gualberti
g****************i@abbvie.com
-
Naoki Wasa
n********a@abbvie.com
-
Zoltan Dezso
z**********o@abbvie.com
-
Reyhaneh Nazarian
r***************n@abbvie.com
-
Nam Bui
n*****i@abbvie.com
-
Dalila Miele
d**********e@abbvie.com
-
Keturah Kiper
k***********r@abbvie.com
-
Andrella King
a***********g@abbvie.com
-
Sana Khajehpour
s*************r@abbvie.com
-
Rebecca Kattan
r************n@abbvie.com
-
Jerry Jacob
j*********b@abbvie.com
-
Heather Huang
h***********g@abbvie.com
-
Catherine Ho
c**********o@abbvie.com
-
Melanie Flores
m************s@abbvie.com
-
Payal Bhatt
p*********t@abbvie.com
-
Laura Gasparini
l*************i@abbvie.com
-
Kartik Anne
k*********e@abbvie.com
-
Minna Abdelaziz
m*************z@abbvie.com
-
Josette Hughes
j************s@abbvie.com
-
Megan Jimerson
m************n@abbvie.com
-
Teresa K Oberlander
t*****************r@abbvie.com
-
Roland Heym
r*********m@abbvie.com
-
Aoi Kurano
a********o@abbvie.com
-
Jeff Onyskiw
j**********w@abbvie.com
-
Jodi Walker
j*********r@abbvie.com
-
Evgenyi Shalaev
e*************v@abbvie.com
-
Yunzhao Xing
y**********g@abbvie.com
-
Aparna Shinde
a***********e@abbvie.com
-
Leonie Hammer
l***********r@abbvie.com
-
Gregory Willocq
g*************q@abbvie.com
-
Bobbi Wiggins
b***********s@abbvie.com
-
Yoosook Kim
y*********m@abbvie.com
-
John Torrisi
j**********i@abbvie.com
-
Barbara Razenberg
b***************g@abbvie.com
-
Matthew Galley
m************y@abbvie.com
-
Emily King
e********g@abbvie.com
-
Gentry Lassiter
g*************r@abbvie.com
-
Elena Karpilovski
e***************i@abbvie.com
-
Liz Shea
l******a@abbvie.com
-
Ilke Limoncu
i**********u@abbvie.com
-
Alyssa Rege
a*********e@abbvie.com
-
Raquel Powers
r***********s@abbvie.com
-
Jeremy Picard
j***********d@abbvie.com
-
Adelle Infante
a************e@abbvie.com
-
Todd Bosse
t********e@abbvie.com
-
Joao N Belo
j*********o@abbvie.com
-
Jaquelin Finley
j*************y@abbvie.com
-
Gerlinde Baldauf
g**************f@abbvie.com
-
V Siparis
v*******s@abbvie.com
-
Jenna Hanson
j**********n@abbvie.com
-
David Wagner
d**********r@abbvie.com
-
Isabelle Petatthiolas
i*******************s@abbvie.com
-
Anisha Manix
a**********x@abbvie.com
-
Jacqueline Karis
j**************s@abbvie.com
-
Suzanne Barston
s*************n@abbvie.com
-
Shannelle Fowler
s**************r@abbvie.com
-
Dana Harville
d***********e@abbvie.com
-
Gabrielle Tarbert
g***************t@abbvie.com
-
Susanne Griffiths
s***************s@abbvie.com
-
Larry Peepo
l*********o@abbvie.com
-
Gregory Miley
g***********y@abbvie.com
-
Courtney Fella
c************a@abbvie.com
-
Jonathan Anderson
j***************n@abbvie.com
-
Jenina Nunez
j**********z@abbvie.com
-
Moiz Diwan
m********n@abbvie.com
-
Tym Lindsey
t*********y@abbvie.com
-
Office At
o*******t@abbvie.com
-
Mandie Judy
m*********y@abbvie.com
-
Fabio Lievano
f***********o@abbvie.com
-
Thao T Doan
t*********n@abbvie.com
-
Peter Bacher
p**********r@abbvie.com
-
Birgitta Bjornek
b**************k@abbvie.com
-
Joy Jacksonguilford
j******************d@abbvie.com
-
Rebecca Kohnken
r*************n@abbvie.com
-
Elizabeth Simms
e*************s@abbvie.com
-
Lucas Chavira
l***********a@abbvie.com
-
David Gardner
d***********r@abbvie.com
-
Juliapaige Yuhase
j***************e@abbvie.com
-
Fernando Bastos
f*************s@abbvie.com
-
Yunhao Tan
y********n@abbvie.com
-
Hongjian Zhu
h**********u@abbvie.com
-
Carlos Hader
c**********r@abbvie.com
-
Samira Mawla
s**********a@abbvie.com
-
Fabian Liboschik
f**************k@abbvie.com
-
Petra Grossmann
p*************n@abbvie.com
-
Anna Samokhvalova
a***************a@abbvie.com
-
Dai Feng
d******g@abbvie.com
-
Iain Boomer
i*********r@abbvie.com
-
Alice Chan
a********n@abbvie.com
-
Megana Vatson
m***********n@abbvie.com
-
Amanda Vogel
a**********l@abbvie.com
-
Jun Yu
j****u@abbvie.com
-
Kevin Zowaski
k***********i@abbvie.com
-
Eva Sebestova
e***********a@abbvie.com
-
Kathrin Kuntz
k***********z@abbvie.com
-
Brian Martin
b**********n@abbvie.com
-
Jijie Gu
j******u@abbvie.com
-
Andrew Shaw
a*********w@abbvie.com
-
Florian Dieckmann
f***************n@abbvie.com
-
David Freundel
d************l@abbvie.com
-
Javier Boix
j*********x@abbvie.com
-
Tamer Hanna
t*********a@abbvie.com
-
Diana L Donnellyroberts
d**********************s@abbvie.com
-
Dayoung Yi
d********i@abbvie.com
-
Renee Heuser
r**********r@abbvie.com
-
Blai Coll
b*******l@abbvie.com
-
Muriel Haraoui
m************i@abbvie.com
-
Daniela Haertel
d*************l@abbvie.com
-
Sanjay Bhardwaj
s*************j@abbvie.com
-
Kaisa Raitio
k**********o@abbvie.com
-
Sabine Grote
s**********e@abbvie.com
-
Johanna Castrillon
j****************n@abbvie.com
-
Veronique Paula
v*************a@abbvie.com
-
Christina Lee
c***********e@abbvie.com
-
Gary Chiang
g*********g@abbvie.com
-
Marketta Piskonen
m***************n@abbvie.com
-
Aman Thukral
a**********l@abbvie.com
-
Julie Lepsetz
j***********z@abbvie.com
-
Hannah Martinez
h*************z@abbvie.com
-
Aris Vasilopoulos
a***************s@abbvie.com
-
Ryota Watanabe
r************e@abbvie.com
-
Takao Nito
t********o@abbvie.com
-
Weili He
w******e@abbvie.com
-
Mabel Martinez
m************z@abbvie.com
-
Devin Slagle
d**********e@abbvie.com
-
Eileen Murphy
e***********y@abbvie.com
-
Giuseppina Zarigno
g****************o@abbvie.com
-
Eric Mohler
e*********r@abbvie.com
-
Min Zhang
m*******g@abbvie.com
-
Terhi Pellinen
t************n@abbvie.com
-
Anne Lejon
a********n@abbvie.com
-
Marcello Rinaldi
m**************i@abbvie.com
-
Ryoichi Kiyohara
r**************a@abbvie.com
-
Jillian Griffin
j*************n@abbvie.com
-
Shuai Hao
s*******o@abbvie.com
-
Jessica Feltman
j*************n@abbvie.com
-
Jeffrey Allan
j***********n@abbvie.com
-
Frank Benenati
f************i@abbvie.com
-
Shashank Shekhar
s**************r@abbvie.com
-
Roxann Stubbs
r***********s@abbvie.com
-
Medha Tomlinson
m*************n@abbvie.com
-
Beatriz Samanes
b*************s@abbvie.com
-
Kate Ferrario
k***********o@abbvie.com
-
Nicole Muraca
n***********a@abbvie.com
-
Jay Lucas
j*******s@abbvie.com
-
Helene Villeneuve
h***************e@abbvie.com
-
Pascal Marcoux
p************x@abbvie.com
-
Nathalie Lavoie
n*************e@abbvie.com
-
Theresia Bredenwall
t*****************l@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
talentacquisition@abbvie.com
-
Unclassified inbox
AbbvieCDO@abbvie.com
-
Unclassified inbox
privacydsr@abbvie.com
-
Unclassified inbox
info-cz@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
switzerland@abbvie.com
-
Unclassified inbox
orders@abbvie.com
-
Unclassified inbox
abbviemediarelations@abbvie.com
-
Unclassified inbox
medical_info_spain@abbvie.com
-
Unclassified inbox
safety-cz@abbvie.com
-
Unclassified inbox
plsproductsurveillanceteam@abbvie.com
-
Customer Service
customerservice@abbvie.com
-
Unclassified inbox
hrconnect.northamerica@abbvie.com
-
Unclassified inbox
abbviepaa@abbvie.com
-
Unclassified inbox
managepd_support_it@abbvie.com
-
Unclassified inbox
library@abbvie.com
-
Unclassified inbox
job-opportunities@abbvie.com
-
Unclassified inbox
sp-assuntos_regulatorios@abbvie.com
-
Unclassified inbox
cs-germany@abbvie.com
-
Customer Service
service@abbvie.com
-
Unclassified inbox
info.de@abbvie.com

HQ: Rahway, New Jersey, United States
Merck is a biopharmaceutical company that offers mShow more...edicines and vaccines for various diseases.
HQ: Rahway, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: 1891
Number of Exits: 9
Company Type: For Profit
Stock Symbol: NYSE:MRK
Operating Status: Active
Main email format: sarah_smith@merck.com (76.9%)
-
Phillip Samayoa
Associate Director, MRL Ventures
p******s@merck.com
-
Lubomir Kamensky
l**************y@merck.com
-
Carolina Colella
c**************a@merck.com
-
Rachel Parise
PhD Candidate - Analytical Chemistry Reseacher
r***********e@merck.com
-
Peter Dudek
Associate
p*********k@merck.com
-
Marc Gailhardou
a VP Global Oncology Strategy at Merck
m*************u@merck.com
-
Jieyun Hao
HR Business Partner
j********o@merck.com
-
Francesca Poggio
f**************o@merck.com
-
Ken Friesen
k*********n@merck.com
-
Austin Snook
a**********k@merck.com
-
Roberta Corsi
r***********i@merck.com
-
Vishal Sahni
Venture Capital advisory committee member, Biofund II
v**********i@merck.com
-
John Minehane
Assistant Production Manager
j***********e@merck.com
-
Cheryl Donnelly
c*************y@merck.com
-
Courtney Ronaldo
c**************o@merck.com
-
Tracy Clemmer
t************2@merck.com
-
Harry Herar
Sales Representative
h*********r@merck.com
-
Andrei Manica
a***********a@merck.com
-
Sergey Zverev
s***********v@merck.com
-
Rehan A Khan
r********n@merck.com
-
Kevin Ali
k*******i@merck.com
-
Kevin Sharpe
k**********e@merck.com
-
Heather Rakestraw
h***************w@merck.com
-
Cedric Grand-Pierre
c****************e@merck.com
-
Joyce. Pennings
j************s@merck.com
-
Anneke Rietveld
Key Account Manager
a*************d@merck.com
-
Legal Department
legal@merck.com

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Main email format: sarah.smith@pfizer.com (92.1%)
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com

HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Main email format: sarah.smith@pfizer.com (92.1%)
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com

HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com

HQ: Minneapolis, Minnesota, United States
Medtronic develops healthcare technology solutionsShow more... for various medical conditions.
HQ: Minneapolis, Minnesota, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active
Main email format: sarah.smith@medtronic.com (94.4%)
-
Omar Ishrak
CEO
o**r@medtronic.com
-
Geoffrey Martha
Chairman & Chief Executive Officer
g*************a@medtronic.com
-
Gisele Osborn
Principal Quality Engineer, Post Market Vigilance
g***********n@medtronic.com
-
Scott Vanderwerf
s**************f@medtronic.com
-
Eric Foster
e*********r@medtronic.com
-
Julie Fischbach
j*************h@medtronic.com
-
Akash Beejawat
a************t@medtronic.com
-
Åsa Grosso
a********o@medtronic.com
-
Sheila Minske
Director of Global Supply Chain Strategy and Innovation at Medtronic
s***********e@medtronic.com
-
Francesca Battistoni
f******************i@medtronic.com
-
Braden Hopps
b**********s@medtronic.com
-
Peter Byron
p*********n@medtronic.com
-
Roy Wilsker
r*********r@medtronic.com
-
Chas Pall
c*******l@medtronic.com
-
Kevin Kelley
Director of Sustainability & Business Development
k**********y@medtronic.com
-
Eoin Keane
e********e@medtronic.com
-
Ben Karel
b*******l@medtronic.com
-
Stephane Moreau
s*************u@medtronic.com
-
Barbara Sandovalabsher
b********************r@medtronic.com
-
Teresita Obra
t***********a@medtronic.com
-
Giacomo Iacomino
g**************o@medtronic.com
-
Raheel Ahmad
r**********d@medtronic.com
-
Alessandro Antico
a***************o@medtronic.com
-
Gal Noiman
Import, Export & Logistics Coordinator
g********n@medtronic.com
-
Unclassified inbox
michelle.r.claypool@medtronic.com
-
Unclassified inbox
RS.MedtronicAcademy@medtronic.com
-
Unclassified inbox
customerservice.portugal@medtronic.com

HQ: Bagsværd, Hovedstaden, Denmark
Novo Nordisk is a healthcare company that producesShow more... and distributes insulin and other diabetes drugs to treat chronic diseases.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Aug 30, 2024
Founded Date: 1923
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:NVO
Operating Status: Active
Main email format: sarah@novonordisk.com (90.9%)
-
Marianne Hedegaard
Service Manager (eDevice/eSolution in Clinical Trials)
c****a@novonordisk.com
-
Maziar Mike Doustdar
Executive Vice President, International Operations
m**d@novonordisk.com
-
Trine Juul Wengel
t***e@novonordisk.com
-
Rasmus Holt
r****s@novonordisk.com
-
Toby Damron
Associate Director, Scientific Strategy & Alignment
t**y@novonordisk.com
-
Anna Borowiecka
Associate Director, GCP and PV Regulatory Compliance
a**a@novonordisk.com
-
Henrik Egesborg
Consultant
h****k@novonordisk.com
-
Christine Andersen
Project Director
c*******e@novonordisk.com
-
Casper Leuenhagen
c****r@novonordisk.com
-
David Flood
d***d@novonordisk.com
-
Cecilie Borregaard
c*****e@novonordisk.com
-
Lif Swaro
l*f@novonordisk.com
-
Else Marie Wollesund
e**e@novonordisk.com
-
Jitendra Maurya
SAP Technical Consultant
j******a@novonordisk.com
-
Zahra Abou Khalil
z***a@novonordisk.com
-
Nyssa Noyola
Summer Associate
n***a@novonordisk.com
-
mohamed IGHMOUR
Opéarteur polyvalent en fabrication
m*****d@novonordisk.com
-
Marcos Moreno
m****s@novonordisk.com
-
Stephanie Padilla
s*******e@novonordisk.com
-
Kanita Salic
k****a@novonordisk.com
-
Jacob de Ripperda
j***b@novonordisk.com
-
Rune Funder Hansen
r**h@novonordisk.com
-
Irene Winther
i***e@novonordisk.com
-
Carmen Sans Arija
Advisor
c****n@novonordisk.com
-
Yasar Salam Patruss
y***r@novonordisk.com
-
Jonas Andersen Helboe
j***s@novonordisk.com
-
Eva Palmqvist
e********t@novonordisk.com
-
Camilla Lenz
c*****a@novonordisk.com
-
Unclassified inbox
nnimediateam@novonordisk.com
-
Unclassified inbox
janed@novonordisk.com
-
General Inquiries
info@novonordisk.gr
-
Unclassified inbox
caio@novonordisk.com
-
Unclassified inbox
prindia@novonordisk.com

HQ: Waltham, Massachusetts, United States
Thermo Fisher Scientific is a biotechnology and laShow more...boratory equipment company that provides a wide range of scientific products and services.
HQ: Waltham, Massachusetts, United States
Specialized In: Biotechnology, Cloud Computing, Coaching & Consulting, Healthcare & Medical, Technology & Software
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1956
Company Type: For Profit
Stock Symbol: BMV:TMO
Operating Status: Active
Main email format: sarah.smith@thermofisher.com (96.3%)
-
Becky Moore
Product Manager
m***e@thermofisher.com
-
Michelle Logan
m************n@thermofisher.com
-
Louise Wilson
Analytical Chemist at Johnson Matthey
l***********n@thermofisher.com
-
Alicia Rosol
a**********l@thermofisher.com
-
Tiffani Manolis
t*************s@thermofisher.com
-
Art Lee
a*****e@thermofisher.com
-
Dimitris Gkirlemis
d****************s@thermofisher.com
-
Enrico Vietri
Principal Consultant
e***********i@thermofisher.com
-
Kim Chai
k******i@thermofisher.com
-
Anand Das
Technology Advisor
a*******s@thermofisher.com
-
Lisa Averns
l*********s@thermofisher.com
-
Erdem Karabulut
Postdoctoral Researcher
e*************t@thermofisher.com
-
Walter Dernelle
w*************e@thermofisher.com
-
Dorine Laheij
d***********j@thermofisher.com
-
Katya Rodriguez
Senior Manager, Global Trade Compliance
k*************z@thermofisher.com
-
Suzanne Graham
Senior Director, Global Business & Sales Development, Electron Microscopy at Thermo Fisher Scientific
s************m@thermofisher.com
-
Jeff Bonevich
j***********h@thermofisher.com
-
Customer Service
fisheruk.productsupport@thermofisher.com
-
Customer Service
PaiGlobalCustomerService@thermofisher.com
-
Unclassified inbox
karen.kirkwood@thermofisher.com
-
Unclassified inbox
unity.at@thermofisher.com
-
Unclassified inbox
oxoid.at@thermofisher.com
-
Unclassified inbox
info.mc.us@thermofisher.com
-
Unclassified inbox
us.customer-support.analyze@thermofisher.com

HQ: Whippany, New Jersey, United States
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com

HQ: Leverkusen, Nordrhein-Westfalen, Germany
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Leverkusen, Nordrhein-Westfalen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
Unclassified inbox
SCIP-BAYER@bayer.com
-
General Inquiries
info@bayer.com
-
Unclassified inbox
caio.inbox@bayer.com

HQ: Whippany, New Jersey, United States
Bayer is a life science company that specializes iShow more...n the areas of health care and agriculture.
HQ: Whippany, New Jersey, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Last Investment Activity: Apr 1, 2024
Founded Date: Aug 1, 1863
Number of Exits: 3
Company Type: For Profit
Stock Symbol: ETR:BAYN
Operating Status: Active
Main email format: sarah.smith@bayer.com (100.0%)
-
Brigitte Gutendorf
Global Marketing Director, Commercial Lead
b****************f@bayer.com
-
Danielle Golay
Head of Quality
d************y@bayer.com
-
Alisa Reinhardt
a*************t@bayer.com
-
Jose Maria Fernandez Guerra
j*********a@bayer.com
-
Rakhshita Dhar
Venture Investments, Pharma
r************r@bayer.com
-
Derek Norman
Vice President, Venture Investments
d**********n@bayer.com
-
Kira Peikoff
Deputy Director, Communications
k**********f@bayer.com
-
Patricia Corsi
p************i@bayer.com
-
Michael Engels
Managing Director Germany / Sub-Region Head DACH
m************s@bayer.com
-
Miguel Medina
m***********a@bayer.com
-
Joris Zimmermann
j**************n@bayer.com
-
Govi Silvia
g*********a@bayer.com
-
Michael Clements
m**************s@bayer.com
-
Dawn Wysepester
d*************r@bayer.com
-
Inge De Pauw
i*********w@bayer.com
-
Pujitha Bandi
p***********i@bayer.com
-
General Inquiries
info@bayer.com

HQ: Cambridge, Cambridgeshire, United Kingdom
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com

HQ: Summit, New Jersey, United States
Celgene discovers, develops and commercializes innShow more...ovative therapies to treat cancer and immune-inflammatory-related diseases.
HQ: Summit, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical
Acquired by: Bristol-Myers Squibb
Business Type: Delisted
Employees: 10001+
Last Investment Activity: May 24, 2024
Founded Date: 1986
Number of Exits: 31
Company Type: For Profit
Stock Symbol: NASDAQ:CELG
Operating Status: Active
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
Unclassified inbox
drugsafety@celgene.com

HQ: New York, New York, United States
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
General Inquiries
hello@bms.com
-
General Inquiries
contact@bms.com
-
Legal Department
legal@bms.com

HQ: Basel, Basel-Stadt, Switzerland
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
David Barton
d********1@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com

HQ: London, England, United Kingdom
GlaxoSmithKline develops and markets products in tShow more...he areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
HQ: London, England, United Kingdom
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Grant
Last Investment Activity: Mar 1, 2024
Founded Date: 1929
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:GSK
Operating Status: Active
Main email format: sarah.smith@gsk.com (93.8%)
-
Yusuf Karagöz
u************z@gsk.com
-
Agnieszka Kowalczyk
a*****************k@gsk.com
-
Nathalie LORET-MAHE
n**************t@gsk.com
-
Jean-Christophe Goirand
j********************d@gsk.com
-
Kirill Nikitin
k************n@gsk.com
-
Vibhu Gupta
v*********a@gsk.com
-
Marine Anciaux
Internship - Emulsion Development Group
m***********x@gsk.com
-
Jeremy England
j************d@gsk.com
-
General Inquiries
info@gsk.com
-
Customer Service
support@gsk.com
-
Sales Department
sales@gsk.com
-
Unclassified inbox
Simon.M.Bicknell@gsk.com

HQ: San Francisco, California, United States
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu

HQ: San Francisco, California, United States
Director of the Lab for Advanced Cytometry (LAC) aShow more...nd the Sony Biotechnology Center at UCSF in the Department of Laboratory Medicine
HQ: San Francisco, California, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: Nov 21, 2023
Founded Date: 1873
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ucsf.edu (100.0%)
-
Coralie Trentesaux
c****************x@ucsf.edu
-
Leonard Telesca
l*************a@ucsf.edu
-
Suraj Rajan
s*********n@ucsf.edu
-
Martha Ockenfelsmartinez
m**********************z@ucsf.edu
-
Nam Woo Cho
n*****o@ucsf.edu
-
Gwendolyn Lee
g***********e@ucsf.edu
-
Monica Getahun
m************n@ucsf.edu
-
Srikar Kollipara
s**************a@ucsf.edu
-
Amy Penn
a******n@ucsf.edu
-
Media Relations
socialmedia@ucsf.edu

HQ: Thousand Oaks, California, United States
Amgen is a biotechnology company that develops andShow more... manufactures human therapeutics for various illnesses and diseases.
HQ: Thousand Oaks, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active
Main email format: ssmith@amgen.com (88.9%)
-
Esteban Santos
Executive Vice President, Operations
e******s@amgen.com
-
Wendy Kusler
w*****r@amgen.com
-
Krupali Patel
k****l@amgen.com
-
Susan Sweeney
s******y@amgen.com
-
Angelinda Chen
Gender Lens Impact Investing Fellow
a***n@amgen.com
-
Daniel Lu
d*u@amgen.com
-
Rex Atienza
r******a@amgen.com
-
Unclassified inbox
HCCIME@amgen.com
-
Unclassified inbox
medinfocanada@amgen.com
-
Unclassified inbox
amgenmediarelations@amgen.com

HQ: Foster City, California, United States
Gilead Sciences is a biopharmaceutical company thaShow more...t discovers, develops, manufactures and commercializes therapies for critical diseases.
HQ: Foster City, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active
Main email format: sarah.smith@gilead.com (82.4%)
-
Ahmed Afifi
Vice President - Region Head Latin America
a*********i@gilead.com
-
Ketki Malgaonkar
Regulatory Affairs Manager
k**************r@gilead.com
-
Abhishek Bachchan
a***************n@gilead.com
-
Yin Jonkman
Compensation and Benefits Manager EMEA a.i
y*********n@gilead.com
-
Ethan Grant
e*********t@gilead.com
-
Karim Lee
k*******e@gilead.com
-
Angie Hertz
a*********z@gilead.com
-
Fatima Farid
f**********d@gilead.com
-
Nara Ramakrishnan
n***************n@gilead.com
-
Unclassified inbox
public_affairs@gilead.com

HQ: Durham, North Carolina, United States
Quintiles is a provider of biopharmaceutical develShow more...opment and commercial outsourcing services for drugs on the market.
HQ: Durham, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Acquired by: IMS Health
Business Type: Delisted
Employees: 10001+
Rounds: Grant
Last Investment Activity: Jan 22, 2024
Founded Date: 1982
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:Q
Operating Status: Active
Main email format: sarah.smith@quintiles.com (100.0%)
-
Brian Kelly
Senior Advisor
p************k@quintiles.com
-
Jara Soltero
j**********o@quintiles.com
-
Hicham Benhaddi
h*************i@quintiles.com
-
Alistair Grenfell
President North Europe, Middle East, Africa and South Asia
a***************l@quintiles.com
-
Diane Brescia
Sr. Recruiter
d***********a@quintiles.com
-
Parag Phad
p********d@quintiles.com
-
Michelle Wilken
Director of Commercial Strategy
m*************n@quintiles.com
-
Jeff Fusco
j********o@quintiles.com
-
Cindy Lam
c*******m@quintiles.com
-
Patrick Daly
Executive In Residence
p**********y@quintiles.com
-
Debalina Pani
d***********i@quintiles.com
-
Fatemeh Tahavori
fatemeh.tahavori@quintiles.com
-
General Inquiries
info@quintiles.com

HQ: Indianapolis, Indiana, United States
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 6, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com

HQ: Indianapolis, Indiana, United States
Eli Lilly engages in the discovery, development, mShow more...anufacture, and sale of pharmaceutical products.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jul 8, 2024
Founded Date: Jan 1, 1876
Number of Exits: 22
Company Type: For Profit
Stock Symbol: EPA:LLY
Operating Status: Active
Main email format: sarah.smith@lilly.com (50.0%)
-
Marie Murphy
Principal Research Scientist, Technical Services Manufacturing Network
mm@lilly.com
-
Violaine Huck
h***********e@lilly.com
-
Anindya Sen
Director at Prevail Therapeutics
s*********a@lilly.com
-
Jessica Witherow
Autoimmune and Rare Disease Specialist
w**************a@lilly.com
-
Gary J Gacek
g********k@lilly.com
-
Lotus Mallbris
l************s@lilly.com
-
Halle Bull
Pharmaceutical Sales Consultant
bull_halle@lilly.com
-
General Inquiries
info@lilly.com

HQ: Cambridge, Massachusetts, United States
Moderna Therapeutics is a biotechnology company thShow more...at specializes in drug discovery and drug development based on messenger RNA.
HQ: Cambridge, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank
Main email format: sarah.smith@modernatx.com (100.0%)
-
Tatiana Novobrantseva
Chief Scientific Officer, Immuno-Oncology Research
t*******************a@modernatx.com
-
Juan Andres
Senior Vice President Technical Development, Manufacturing and Quality
j*********s@modernatx.com
-
Nidal El Assi
Associate Director Of Lab Operations
n********i@modernatx.com
-
Lavina Talukdar
l*************r@modernatx.com
-
Shannon Thyme Klinger
Chief Legal Officer at Moderna
s*************r@modernatx.com
-
Gamal Elfatarany
g**************y@modernatx.com
-
Unclassified inbox
WeCare@modernatx.com
-
Unclassified inbox
Grace.Chen@modernatx.com
-
General Inquiries
info@modernatx.com

HQ: Boston, Massachusetts, United States
Vertex Pharmaceuticals is focused on the discoveryShow more... and development of small molecule drugs for the treatment of serious diseases.
HQ: Boston, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active
Main email format: sarah_smith@vrtx.com (64.3%)
-
Mark Yu
Senior Research Associate
m*****u@vrtx.com
-
Isaac Vasanthkumar
i****************r@vrtx.com
-
Guoxiang Ruan
g***********n@vrtx.com
-
Phillip Snyder
p************r@vrtx.com
-
Mac Johnson
Senior Director, Research, Vertex Pharmaceuticals
m*********n@vrtx.com
-
Morrey Atkinson
m*************n@vrtx.com
-
General Inquiries
mediainfo@vrtx.com

HQ: Nashville, Tennessee, United States
Hospital Corporation of America (HCA) provides heaShow more...lthcare services in locally managed facilities in 20 states in the U.S. and England.
HQ: Nashville, Tennessee, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: Nov 22, 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:HCA
Operating Status: Active
Investor Type: Micro VC, Venture Capital
Main email format: sarah.smith@hcahealthcare.com (100.0%)
-
Eun So
e****o@hcahealthcare.com
-
Janice Lamy
j*********y@hcahealthcare.com
-
Debra Franklin
d************n@hcahealthcare.com
-
Sharmen Jackson
Pharmacist
s*************n@hcahealthcare.com
-
Vicki Patterson
v*************n@hcahealthcare.com
-
Diego Arboleda
Manager
d************a@hcahealthcare.com
-
William Vicinanza
william.vicinanza@hcahealthcare.com
-
General Inquiries
info@hcahealthcare.com

HQ: Burlington, North Carolina, United States
Labcorp specializes in providing physicians with lShow more...aboratory tests.
HQ: Burlington, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 20, 2024
Founded Date: Sep 5, 1978
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NYSE:LH
Operating Status: Active
Main email format: sarah.smith@labcorp.com (72.7%)
-
Araceli Reyes
Divisional Medical Director, Northeast Division
a***********s@labcorp.com
-
Drew Barile
Venture Capitalist Interviewer & Story Producer/ Brand Ambassador
bd@labcorp.com
-
Customer Service
LCWebsiteSupport@labcorp.com
-
Unclassified inbox
koester@labcorp.com

HQ: Basel, Basel-Stadt, Switzerland
Lonza Group supplies products and services to pharShow more...maceutical and agrochemical industries.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1897
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:LONN
Operating Status: Active
Main email format: sarah.smith@lonza.com (100.0%)
-
Alice Harrison
Global Technical Director
a************n@lonza.com
-
Thomas Stuenkel
t*************l@lonza.com
-
Elissa Goldstein
e**************n@lonza.com
-
Wolfgang Zimmerer
z***************g@lonza.com
-
General Inquiries
info@lonza.com
-
Admin Team
admin@lonza.com
-
General Inquiries
contact@lonza.com

HQ: Chicago, Illinois, United States
Tempus is a technology company advancing precisionShow more... medicine through the practical application of artificial intelligence in healthcare.
HQ: Chicago, Illinois, United States
Specialized In: AI & Machine Learning, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 501-1000
Rounds: Debt Financing
Last Investment Activity: Mar 27, 2024
Founded Date: 2015
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@tempus.com (76.9%)
-
Ryan Fukushima
Chief Operating Officer
r**n@tempus.com
************0
-
Martin Stumpe
Chief of AI
m***********e@tempus.com
***********9
-
Bogdan Ivan
b*********n@tempus.com
-
Lauren Silvis
Board of Directors
l***********s@tempus.com
-
Nicole Bean
Associate Director of Promotional Marketing ✦ Corporate Brand Identity ✦ Social Media Marketing
n*********n@tempus.com
-
Laura Pausch
Commercial Operations Associate
l***a@tempus.com
-
Rohini Yadav
Senior Software Engineer
r**********v@tempus.com
-
Daria Tarasova
Senior Software Engineer
d************a@tempus.com
-
Colin Meret
Senior Site Reliability Engineer
c*********t@tempus.com
-
Eric Lefkofsky
Founder
e**c@tempus.com
-
Riccardo Miotto
Director of Machine Learning
r*************o@tempus.com
-
Shane Colley
CTO
s**********y@tempus.com
-
Erik Phelps
Executive Vice President, Chief Administrative and Legal Officer
e*********s@tempus.com
-
Admin Team
admin@tempus.com
-
Customer Service
support@tempus.com
-
General Inquiries
contact@tempus.com
-
General Inquiries
feedback@tempus.com
-
General Inquiries
help@tempus.com
-
Media Relations
media@tempus.com

HQ: Temple City, California, United States
Fulgent Therapeutics, LLC is a pharmaceutical compShow more...any focusing on developing and commercializing innovative cancer therapeutics.
HQ: Temple City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Nov 7, 2022
Founded Date: 2011
Company Type: For Profit
Stock Symbol: NASDAQ:FLGT
Operating Status: Active
Main email format: ssmith@fulgentgenetics.com (69.2%)
-
James Liu
Director of System Architecture,Enterprise Systems Architect
j**u@fulgentgenetics.com
-
Ming Hsieh
m*******h@fulgentgenetics.com
-
Rod Gervacio
CLS Lead
r*******o@fulgentgenetics.com
-
Spencer Young
Solutions/Software Analyst/Scientist/Engineer
s****g@fulgentgenetics.com
-
Benjamin Ramos
Talent Acquisition Specialist
b****s@fulgentgenetics.com
-
Doreen Ng
VP, Operations & Compliance | General Manager (Houston)
d******g@fulgentgenetics.com
-
Natalie Prescott
General Counsel & Chief Privacy Officer
n*******t@fulgentgenetics.com
-
Hanlin Gao
Lab Director and Chief Scientific Officer
h**o@fulgentgenetics.com
-
Paul Kim
Chief Financial Officer
p**m@fulgentgenetics.com
-
General Inquiries
info@fulgentgenetics.com
-
Customer Service
lacsupport@fulgentgenetics.com
-
Unclassified inbox
insurance@fulgentgenetics.com
-
General Inquiries
info@fulgent-therapeutics.com

HQ: Dublin, Dublin, Ireland
Global Healthcare Products Leader
HQ: Dublin, Dublin, Ireland
Specialized In: Biotechnology, Electronics, Healthcare & Medical
Acquired by: Medtronic
Business Type: Delisted
Employees: 10001+
Last Investment Activity: Jul 4, 2023
Founded Date: 2007
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:COV
Operating Status: Closed
Investor Type: Venture Capital
Main email format: sarah.smith@covidien.com (100.0%)
-
Charles Travis
Director, Field Medical Affairs Team at Ascendis Pharma A/S
c************s@covidien.com
-
Jennifer Radmer CAP-OM-TA, MOS
j*************r@covidien.com
-
Lisa French
U.S. Women's Health Business Unit Lead
l*********h@covidien.com
-
Kristi Winger Szudlo
Autoimmune and Rare Disease Specialist
k***********o@covidien.com
-
Unclassified inbox
Paulgregory0000@gmail.com

HQ: Northbrook, Illinois, United States
Horizon Therapeutics focuses on the development ofShow more... prescription drugs for mild to moderate pain relief and arthritis.
HQ: Northbrook, Illinois, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active
Main email format: ssmith@horizontherapeutics.com (54.5%)
-
John Croatt
Regional Account Director
j*********t@horizontherapeutics.com
-
Liz Gutierrez
l********z@horizontherapeutics.com
-
Susanna Frydryk
s******k@horizontherapeutics.com
-
Customer Service
customerservice@horizontherapeutics.com
-
Unclassified inbox
jwhalen@horizonpharma.com

HQ: Irvine, California, United States
Edwards Lifesciences is a provider of science of hShow more...eart valves and hemodynamic monitoring.
HQ: Irvine, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Aug 19, 2024
Founded Date: Jan 1, 1958
Number of Exits: 7
Company Type: For Profit
Stock Symbol: BMV:EW
Operating Status: Active
Main email format: sarah_smith@edwards.com (100.0%)
-
Marc Ioos
m*******s@edwards.com
-
Olgu Icoz Peng
Senior Program Manager at Thales Avionics
o*******g@edwards.com
-
General Inquiries
info@edwards.com
-
Customer Service
tech_support@edwards.com

HQ: Dublin, Dublin, Ireland
Global Healthcare Products Leader
HQ: Dublin, Dublin, Ireland
Specialized In: Biotechnology, Electronics, Healthcare & Medical
Acquired by: Medtronic
Business Type: Delisted
Employees: 10001+
Last Investment Activity: Jul 4, 2023
Founded Date: 2007
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NYSE:COV
Operating Status: Closed
Investor Type: Venture Capital
Main email format: sarah.smith@covidien.com (100.0%)
-
Charles Travis
Director, Field Medical Affairs Team at Ascendis Pharma A/S
c************s@covidien.com
-
Jennifer Radmer CAP-OM-TA, MOS
j*************r@covidien.com
-
Lisa French
U.S. Women's Health Business Unit Lead
l*********h@covidien.com
-
Kristi Winger Szudlo
Autoimmune and Rare Disease Specialist
k***********o@covidien.com
-
Unclassified inbox
Paulgregory0000@gmail.com

HQ: Melbourne, Victoria, Australia
CSL develops innovative biotherapies and influenzaShow more... vaccines that save lives, and help people with life-threatening medical conditions.
HQ: Melbourne, Victoria, Australia
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Apr 25, 2024
Founded Date: Jan 1, 1916
Company Type: For Profit
Stock Symbol: ASX:CSL
Operating Status: Active
Main email format: sarahs@csl.com (66.7%)
-
Joy Linton
Chief Financial Officer
j********n@csl.com
-
Reynir Svavar Eiríksson
r**************n@csl.com
-
Alexandra Christodoulopoulou
International Health Economics & Reimbursement Senior Manager
a**************************u@csl.com
-
Brian Dudt
b****d@csl.com
-
Marije Van Huffel
m**************l@csl.com
-
Unclassified inbox
web.queries@computershare.com.au

HQ: San Carlos, California, United States
Natera specializes in cell-free DNA testing to proShow more...vide a more targeted interventions to oncology, women's health, and organ health.
HQ: San Carlos, California, United States
Specialized In: Biotechnology, Health Diagnostics, Healthcare & Medical
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 29, 2024
Founded Date: 2004
Company Type: For Profit
Stock Symbol: FRA:45E
Operating Status: Active
Main email format: ssmith@natera.com (100.0%)
-
Matthew Rabinowitz
CEO, Co-Founder & Executive Chairman
m*********z@natera.com
-
Asaf Sadowsky
Director, Product Management
a*******y@natera.com
-
Semeret Wolde
s****e@natera.com
-
General Inquiries
info@natera.com

HQ: Tarrytown, New York, United States
Regeneron Pharmaceuticals specializes in the discoShow more...very, development, and commercialization of innovative medicines.
HQ: Tarrytown, New York, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Sep 6, 2024
Venture Stage: Early Stage Venture
Founded Date: 1988
Number of Exits: obfuscatedobfuscated
Company Type: For Profit
Stock Symbol: NASDAQ:REGN
Operating Status: Active
Main email format: sarah.smith@regeneron.com (100.0%)
-
Boris Gorovits
b************s@regeneron.com
-
Jacky Space
j**************e@regeneron.com
-
Petra Rietschel
Senior Director Clinical Development ImmunoOncology
p*************l@regeneron.com
-
Catherine Armstrong Bccl
c************l@regeneron.com
-
Mena Soliman
m**********n@regeneron.com
-
Heather Hammond
h*************d@regeneron.com
-
Sarah Ghosh
s*********h@regeneron.com
-
Sofia Caruso
s**********o@regeneron.com
-
Jimmy Sanders
j***********s@regeneron.com
-
Lisa Flanagan
Director, Patent Attorney- Therapeutics IP
l***********n@regeneron.com
-
Madison Lee
madison.lee@regeneron.com
-
General Inquiries
info@regeneron.com

HQ: Los Angeles, California, United States
Kite Pharma is a development-stage biotechnology cShow more...ompany designing and developing immune-based therapies to treat cancer indications.
HQ: Los Angeles, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Delisted
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Nov 30, 2023
Founded Date: 2009
Number of Exits: 4
Company Type: For Profit
Stock Symbol: NASDAQ:KITE
Operating Status: Active
Investor Type: Venture Capital
Main email format: ssmith@kitepharma.com (100.0%)
-
Lynn Wondergem
IT Business Partner
l********m@kitepharma.com
-
General Inquiries
info@kitepharma.com

HQ: Durham, North Carolina, United States
KBI Biopharma, Inc. (KBI) is a leading developmentShow more... and contract manufacturing organization serving the biopharmaceutical industry. We help
HQ: Durham, North Carolina, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial
Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@kbibiopharma.com (100.0%)
-
Chioma Otti
Microbiology Specialist
c***i@kbibiopharma.com
-
Marykay Marchigiani
Chief Financial Officer
m**********i@kbibiopharma.com
-
Unclassified inbox
swakefield@kbibiopharma.com
-
General Inquiries
contact@kbibiopharma.com

HQ: Chelmsford, Massachusetts, United States
ZOLL Medical Corporation, an Asahi Kasei Group comShow more...pany, develops and markets medical devices and software solutions.
HQ: Chelmsford, Massachusetts, United States
Specialized In: Biotechnology, Fitness, Healthcare & Medical, Technology & Software
Acquired by: Asahi Kasei
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Mar 20, 2023
Founded Date: 1980
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@zoll.com (87.5%)

HQ: Mumbai, Maharashtra, India
Cipla is a drug manufacturing company that focusesShow more... on a variety of pharmaceutical products.
HQ: Mumbai, Maharashtra, India
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 10001+
Last Investment Activity: Jul 28, 2024
Founded Date: 1935
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NSE:CIPLA
Operating Status: Active
Main email format: sarah.smith@cipla.com (90.0%)
-
Samina Vaziralli
Global Head - Strategy & New Ventures
s****a@cipla.com
-
Satyen Manikani
s*************i@cipla.com
-
General Inquiries
contactus@cipla.com
-
Unclassified inbox
Cipla.cs@cipla.com
-
General Inquiries
Contact@cipla.com
-
Unclassified inbox
drugsafety@cipla.com

HQ: San Diego, California, United States
Sorrento Therapeutics is focused on the developmenShow more...t of proprietary drug therapeutics for addressing unmet medical needs.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 27, 2024
Founded Date: 2006
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:SRNE
Operating Status: Active
Main email format: ssmith@sorrentotherapeutics.com (100.0%)
-
Jaisim Shah
President & Chief Executive Officer
j***h@sorrentotherapeutics.com
-
Dean Ferrigno
Vice President Of Finance
d*******o@sorrentotherapeutics.com
-
Ryan Tang
It Director
r***g@sorrentotherapeutics.com
-
Meredith Childers
Senior Writer
m*******s@sorrentotherapeutics.com
-
General Inquiries
info@sorrentotherapeutics.com
-
Admin Team
admin@sorrentotherapeutics.com
-
Management Department
manager@sorrentotherapeutics.com
-
Legal Department
legal@sorrentotherapeutics.com

HQ: Palo Alto, California, United States
Jazz Pharmaceuticals is a specialty pharmaceuticalShow more... company that identifies, develops and commercializes innovative treatments.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active
Main email format: sarah.smith@jazzpharma.com (100.0%)
-
Bruce Cozadd
Chief Executive Officer
b**********d@jazzpharma.com
-
Todd Johnson
t**********n@jazzpharma.com
-
Robert Fell
r*********l@jazzpharma.com
-
Temire Bobegbe
t************e@jazzpharma.com
-
General Inquiries
investorinfo@jazzpharma.com
-
General Inquiries
contact@jazzpharma.com

HQ: Seattle, Washington, United States
Seattle Children’s is a Non-profit organisation.
HQ: Seattle, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Travel & Hospitality
Business Type: Private
Employees: 10001+
Rounds: Grant
Last Investment Activity: May 29, 2024
Founded Date: 1907
Company Type: Non-profit
Operating Status: Active
Main email format: sarah.smith@seattlechildrens.org (100.0%)
-
Suzanne Seo
s*********o@seattlechildrens.org
-
Gina Sadowski
g***********i@seattlechildrens.org
-
Unclassified inbox
askus@seattlechildrens.org

HQ: Bagsværd, Hovedstaden, Denmark
Novozymes is the world leader in bioinnovation.
HQ: Bagsværd, Hovedstaden, Denmark
Specialized In: Biotechnology, Energy & Utilities
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jul 22, 2024
Founded Date: 2000
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:NZYM-B
Operating Status: Active
Main email format: sarah@novozymes.com (40.0%)
-
Henry Xiang
Chairman
x***g@novozymes.com
-
Annelise Vidø
a******e@novozymes.com
-
Unclassified inbox
swm@novozymes.com

HQ: Hyderabad, Andhra Pradesh, India
Dr. Reddy’s Laboratories is an integrated pharmaceShow more...utical company committed to accelerating access to affordable & innovative medicines.
HQ: Hyderabad, Andhra Pradesh, India
Specialized In: Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: May 29, 2024
Founded Date: Feb 24, 1984
Company Type: For Profit
Stock Symbol: FRA:RDDA
Operating Status: Active
Main email format: sarahsmith@drreddys.com (50.0%)
-
Marc Kikuchi
Chief Executive Officer
m******i@drreddys.com
-
Customer Service
customerservices@drreddys.com
-
Unclassified inbox
dataprivacy@drreddys.com
-
Unclassified inbox
api@drreddys.com
-
Unclassified inbox
shares@drreddys.com
-
Media Relations
socialmedia@drreddys.com

HQ: San Diego, California, United States
NuVasive is a medical device company that creates Show more...minimally invasive surgical products and procedurally integrated spine solutions.
HQ: San Diego, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Acquired by: Globus Medical
Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 16, 2024
Founded Date: Jan 1, 1997
Company Type: For Profit
Stock Symbol: NASDAQ:NUVA
Operating Status: Active
Main email format: ssmith@nuvasive.com (100.0%)
-
Unclassified inbox
ncspatientcare@nuvasive.com
-
Unclassified inbox
NSF@nuvasive.com
-
Unclassified inbox
abcdefghij@nuvasive.com
-
Unclassified inbox
privacy@nuvasive.com
-
General Inquiries
info@nuvasive.com

HQ: New York, New York, United States
Loxo Oncology is a biopharmaceutical company focusShow more...ed on targeted cancer therapies for genetically-defined patient populations.
HQ: New York, New York, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Oct 17, 2022
Founded Date: 2013
Company Type: For Profit
Stock Symbol: NASDAQ:LOXO
Operating Status: Active
Main email format: ssmith@loxooncology.com (87.5%)
-
Ipsita Roy
Sr. Program/Project Manager
i**y@loxooncology.com
-
Nisha Nanda
Director, Clinical Science and Development
n***a@loxooncology.com
-
General Inquiries
info@loxooncology.com
-
Unclassified inbox
clinicaltrials@loxooncology.com

HQ: Boston, Massachusetts, United States
Ginkgo Bioworks is a developer of biological enginShow more...eering products and custom microbes across multiple markets.
HQ: Boston, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 27, 2024
Founded Date: 2008
Number of Exits: 1
Company Type: For Profit
Stock Symbol: BMV:DNA
Operating Status: Active
Main email format: sarah@ginkgobioworks.com (62.5%)
-
Ken Situ
It Consultant
k******u@ginkgobioworks.com
-
General Inquiries
info@ginkgobioworks.com

HQ: Princeton, New Jersey, United States
Integra LifeSciences is an integrated medical deviShow more...ce company.
HQ: Princeton, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 11, 2024
Founded Date: 1989
Company Type: For Profit
Stock Symbol: NASDAQ:IART
Operating Status: Active
Main email format: sarah.smith@integralife.com (100.0%)
-
Stuart Essig
Chairman of the Board
s**********g@integralife.com
-
General Inquiries
info@integralife.com
-
Customer Service
support@integralife.com
-
Sales Department
sales@integralife.com
-
General Inquiries
feedback@integralife.com
-
Unclassified inbox
custsvcnj@integralife.com

HQ: Dallas, Texas, United States
Tenet Healthcare Corporation is one of the largestShow more... investor-owned health care delivery systems in the nation.
HQ: Dallas, Texas, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Jun 23, 2023
Founded Date: 1967
Number of Exits: 6
Company Type: For Profit
Stock Symbol: NYSE:THC
Operating Status: Active
Main email format: sarah.smith@tenethealth.com (100.0%)
-
Zoran Draganic
z************c@tenethealth.com
-
Jana Durfee
jana.durfee@tenethealth.com
-
General Inquiries
info@tenethealth.com

HQ: Heerlen, Limburg, The Netherlands
DSM is a global science-based company active in heShow more...alth, nutrition and materials. By connecting its unique competences in Life Sciences.
HQ: Heerlen, Limburg, The Netherlands
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 30, 2024
Founded Date: 1902
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCQX:RDSMY
Operating Status: Active
Main email format: sarah.smith@dsm.com (100.0%)

HQ: Minneapolis, Minnesota, United States
Bio-Techne is a supplier of tools for life scienceShow more... research, therapeutic manufacturing, and clinical diagnostics.
HQ: Minneapolis, Minnesota, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 7, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:TECH
Operating Status: Active
Main email format: sarah.smith@bio-techne.com (100.0%)

HQ: Kvistgaard, Hovedstaden, Denmark
Bavarian Nordic is a industrial biotechnology compShow more...any developing and producing novel vaccines for the treatment and prevention.
HQ: Kvistgaard, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Dec 22, 2023
Founded Date: 1994
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCPINK:BVNRY
Operating Status: Active
Main email format: sarah.smith@bavarian-nordic.com (85.7%)

HQ: Avon, Connecticut, United States
Magellan Health Services is a healthcare managemenShow more...t organization that focuses on managing behavioral healthcare and diagnostic imaging.
HQ: Avon, Connecticut, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Acquired by: Evolent Health
Business Type: Public
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Mar 23, 2023
Founded Date: 1969
Company Type: For Profit
Stock Symbol: NASDAQ:MGLN
Operating Status: Active
Main email format: ssmith@magellanhealth.com (66.7%)

HQ: Madison, Wisconsin, United States
Allergan is a global pharmaceutical company.
HQ: Madison, Wisconsin, United States
Specialized In: Biotechnology, Education & E-learning, Healthcare & Medical, Pharmaceuticals, Universities & Colleges
Acquired by: AbbVie
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 13, 2024
Founded Date: 1948
Company Type: For Profit
Stock Symbol: NYSE:AGN
Operating Status: Active
-
George Saltzberg
s**************e@allergan.com
-
Sharon DeFeo
defeo_sharon@allergan.com
-
General Inquiries
info@allergan.com

HQ: Redwood City, California, United States
Guardant Health is a precision oncology company thShow more...at uses blood tests, data sets, and analytics to provide treatment to cancer patients.
HQ: Redwood City, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 6, 2024
Founded Date: 2012
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:GH
Operating Status: Active
Main email format: ssmith@guardanthealth.com (100.0%)

HQ: Bothell, Washington, United States
Seagen is a clinical-stage biotechnology company dShow more...edicated to improving patient outcomes with advanced antibody-drug conjugate technology.
HQ: Bothell, Washington, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active
Main email format: ssmith@seagen.com (83.3%)
-
Peter Senter
VP, Chemistry,VP, Distinguished Research Fellow
p***r@seagen.com
-
Marcel Koopman
International Product Manager Oncology
m******n@seagen.com
-
Jayeshkumar Soneji
j*****i@seagen.com
-
General Inquiries
contact@seagen.com

HQ: Albany, New York, United States
“Albany Molecular Research Inc. provides scientifiShow more...c services, products and technologies that improve quality of life while delivering
HQ: Albany, New York, United States
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Delisted
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 20, 2021
Founded Date: 1991
Company Type: For Profit
Stock Symbol: NASDAQ:AMRI
Operating Status: Active
Main email format: sarah.smith@amriglobal.com (100.0%)
-
Steven Pawlows
Senior Manager
s************s@amriglobal.com
-
Ikia Pwalther
Senior Director Business Development
i***********r@amriglobal.com
-
General Inquiries
InvestorInfo@amriglobal.com
-
Unclassified inbox
patty.eisenhaur@amriglobal.com
-
Unclassified inbox
seena.sankar@amriglobal.com

HQ: San Diego, California, United States
Mirati Therapeutics is a Biotechnology company locShow more...ated in 9363 Towne Centre Dr, San Diego, CA, United States.
HQ: San Diego, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Jan 24, 2024
Founded Date: Dec 13, 1995
Company Type: For Profit
Stock Symbol: NASDAQ:MRTX
Operating Status: Active
Main email format: ssmith@mirati.com (60.0%)
-
James Christensen
Chief Scientific Officer
c**********j@mirati.com
-
Lisa Trapp
Senior Director, Finance
l****p@mirati.com
-
General Inquiries
info@mirati.com

HQ: Pittsburgh, Pennsylvania, United States
UPMC is one of the leading nonprofit health systemShow more...s in the United States. A $10 billion integrated global health enterprise headquartered
HQ: Pittsburgh, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Aug 29, 2024
Founded Date: 1893
Number of Exits: 10
Company Type: For Profit
Operating Status: Active
Investor Type: University Program
Main email format: sarah.smith@upmc.com (57.1%)
-
Anna Mamo
Business Development Analyst
a**a@upmc.com
-
Reimi Vrabel
Project Coordinator
r**********l@upmc.com
-
Shunqiao Huang
s************g@upmc.com
-
James Bauersmith
Vice President
j***s@upmc.com
-
Tyler Crawford
Manager - Investments & Transactions, Strategic Finance
tyler@upmc.com
-
General Inquiries
info@upmc.com

HQ: Richmond, Virginia, United States
Indivior is a specialty pharmaceuticals business.
HQ: Richmond, Virginia, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 21, 2024
Founded Date: 2014
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:INDV
Operating Status: Active
Main email format: sarah.smith@indivior.com (100.0%)

HQ: Cambridge, Massachusetts, United States
Genzyme Corporation (Genzyme) is a biotechnology cShow more...ompany. The Company's product and service portfolio is focused on rare genetic disease
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology
Business Type: Private
Employees: 10001+
Last Investment Activity: Jul 30, 2024
Founded Date: 1981
Number of Exits: 3
Company Type: For Profit
Operating Status: Closed
Main email format: sarah.smith@genzyme.com (100.0%)
-
Eliana Clark
Chief Technical Officer
e**********k@genzyme.com
-
Morrill Reynolds
Principal Project Manager
m**************s@genzyme.com
-
Louise Harney
louise.harney@genzyme.com
-
General Inquiries
info@genzyme.com

HQ: Hørsholm, Hovedstaden, Denmark
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Mar 4, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com

HQ: Marcy-l'etoile, Rhone-Alpes, France
bioMérieux develops and produces in vitro diagnostShow more...ic solutions for private and hospital laboratories, mainly for the diagnosis.
HQ: Marcy-l'etoile, Rhone-Alpes, France
Specialized In: Biotechnology, Health Diagnostics, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Last Investment Activity: Sep 5, 2024
Founded Date: 1963
Number of Exits: 3
Company Type: For Profit
Stock Symbol: EPA:BIM
Operating Status: Active
Main email format: sarah.smith@biomerieux.com (100.0%)
-
Arnaud FAVRY
Patient value strategy and public & governmental affairs manager at bioMérieux
a**********y@biomerieux.com
-
General Inquiries
info@biomerieux.com
-
Admin Team
admin@biomerieux.com
-
Customer Service
support@biomerieux.com

HQ: Saint-prex, Vaud, Switzerland
Ferring is a biopharmaceutical company that develoShow more...ps reproductive medicine for healthacare sectors.
HQ: Saint-prex, Vaud, Switzerland
Specialized In: Biotechnology, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Debt Financing
Last Investment Activity: Jan 16, 2024
Founded Date: 1950
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@ferring.com (100.0%)
-
General Inquiries
info@ferring.com
-
Admin Team
admin@ferring.com
-
Investor Relations
investor@ferring.com
-
General Inquiries
contact@ferring.com
-
Sales Department
sales@ferring.com

HQ: Burlington, Massachusetts, United States
inVentiv Health offers clinical and commercial proShow more...fessional services to help biopharmaceutical companies streamline their processes.
HQ: Burlington, Massachusetts, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 10001+
Rounds: Private Equity
Last Investment Activity: Jan 11, 2018
Founded Date: 1996
Number of Exits: 1
Company Type: For Profit
Operating Status: Closed
Main email format: sarah.smith@inventivhealth.com (100.0%)
-
Thomas Carlo Maria Topini
thomas.topini@inventivhealth.com
-
General Inquiries
info@inventivhealth.com

HQ: Castres-gironde, Aquitaine, France
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com

HQ: Castres-gironde, Aquitaine, France
Pierre Fabre is a pharmaceutical manufacturing firShow more...m that supplies skincare, haircare, personal care, and dermo cosmetic products.
HQ: Castres-gironde, Aquitaine, France
Specialized In: Biotechnology, Pharmaceuticals, Hospitals & Clinics
Business Type: Private
Employees: 10001+
Last Investment Activity: Jun 1, 2024
Founded Date: 1961
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@pierre-fabre.com (100.0%)
-
Jacqueline Flam
Vice President Of Marketing
j*************m@pierre-fabre.com
-
Unclassified inbox
contact.pf@pierre-fabre.com

HQ: Cambridge, Cambridgeshire, United Kingdom
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com

HQ: Hørsholm, Hovedstaden, Denmark
ALK is a global research-driven pharmaceutical comShow more...pany that focuses on prevention, diagnosis and treatment of allergies.
HQ: Hørsholm, Hovedstaden, Denmark
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 27, 2024
Founded Date: 1923
Number of Exits: 1
Company Type: For Profit
Stock Symbol: CPH:ALK
Operating Status: Active
Main email format: sarah.smith@alk-abello.com (83.3%)
-
Suna Said
Founder and CEO
s******d@gmail.com
-
Unclassified inbox
reception@alk-abello.com
-
Customer Service
customer.service@alk-abello.com
-
Unclassified inbox
f.bayard@alk-abello.com

HQ: Göttingen, Niedersachsen, Germany
Sartorius helps its customers to develop and manufShow more...acture biotech medicines reliably, quickly, and economically.
HQ: Göttingen, Niedersachsen, Germany
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 18, 2024
Founded Date: 1870
Company Type: For Profit
Stock Symbol: ETR:SRT3
Operating Status: Active
Main email format: sarah.smith@sartorius.com (100.0%)
-
Joachim Kreuzburg
Chairman of the Executive Board and CEO
j***************g@sartorius.com
-
General Inquiries
info@sartorius.com
-
Admin Team
admin@sartorius.com
-
General Inquiries
info@sartorius-stedim.com

HQ: South Plainfield, New Jersey, United States
PTC Therapeutics is a biopharmaceutical company thShow more...at engages in the discovery, development and commercialization of small-molecule drugs.
HQ: South Plainfield, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 19, 2024
Founded Date: 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:PTCT
Operating Status: Active
Main email format: ssmith@ptcbio.com (66.7%)
-
Peter P. Giannousis
Vice President Technical Operations
p*********s@ptcbio.com
-
Ludovic Baillon
Investment Analyst
l************n@ptcbio.com
-
General Inquiries
info@ptcbio.com
-
Unclassified inbox
Info.Nordic@ptcbio.com
-
Unclassified inbox
pharmacovigilance@ptcbio.com
-
General Inquiries
usmedinfo@ptcbio.com

HQ: Stamford, Connecticut, United States
Purdue Pharma develops, manufactures, and markets Show more...medications and consumer health products.
HQ: Stamford, Connecticut, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Private
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Dec 4, 2023
Founded Date: 1892
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@purduepharma.com (50.0%)
-
Bill Watson
w****n@purduepharma.com
-
Heather Jordan
Industry Account Executive at SAP
j****n@purduepharma.com
-
Stephen Rayda
Global Head of Infrastructure and Client Services at Purdue Pharma L.P.
s***********a@purduepharma.com
-
Donna Krizik
Experienced Marketing Director | SEO | B2B Marketer | Content Strategist
dk@purduepharma.com
-
Marc Kesselman
S.V.P. & General Counsel
m************n@purduepharma.com
-
General Inquiries
purduemedInfo@pharma.com

HQ: Novato, California, United States
Ultragenyx Pharmaceutical focuses on the developmeShow more...nt of various products for the treatment of rare and ultra-rare diseases.
HQ: Novato, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Feb 26, 2024
Founded Date: 2010
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:RARE
Operating Status: Active
Main email format: ssmith@ultragenyx.com (83.3%)
-
John Klock
Founder
j**n@ultragenyx.com
-
Xiaohui Lu
Senior Research Scientist
x*u@ultragenyx.com
-
General Inquiries
info@ultragenyx.com
-
Unclassified inbox
trialrecruitment@ultragenyx.com
-
Unclassified inbox
MCorley@ultragenyx.com

HQ: Cambridge, Massachusetts, United States
Cullinan Oncology is a developer of an externally Show more...sourced cancer therapeutics used to end a drug program quickly.
HQ: Cambridge, Massachusetts, United States
Specialized In: Pharmaceuticals, Biotechnology, Medical Devices, Hospitals & Clinics
Business Type: Public
Employees: 11-50
Rounds: Post-IPO Equity
Last Investment Activity: Mar 14, 2024
Founded Date: 2017
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:CGEM
Operating Status: Active
Main email format: ssmith@cullinanoncology.com (100.0%)

HQ: Shanghai, Shanghai, China
Fosun Pharma is a pharmaceutical company.
HQ: Shanghai, Shanghai, China
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Debt Financing
Last Investment Activity: Mar 14, 2024
Founded Date: 1994
Number of Exits: 11
Company Type: For Profit
Stock Symbol: HKG:2196
Operating Status: Active
Investor Type: Venture Capital
Main email format: smiths@fosunpharma.com (83.3%)
-
Alex Zhu
Executive Director
z**a@fosunpharma.com
-
Zhu Xi
z*u@fosunpharma.com
-
Mike Xu
Co-President
x*m@fosunpharma.com
-
Investor Relations
ir@fosunpharma.com
-
Unclassified inbox
info.usa@fosunpharma.com
-
Unclassified inbox
fosunpharma@wsfg.hk
-
Unclassified inbox
int@fosunpharma.com
-
Unclassified inbox
LastF@fosunpharma.com
-
Unclassified inbox
lianzhengdc@fosunpharma.com

HQ: New York, New York, United States
Flatiron Health is a healthcare technology companyShow more... that aims to improve lives by learning from the experience of every cancer patient.
HQ: New York, New York, United States
Specialized In: Biotechnology, Cloud Computing, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 1001-5000
Rounds: Series D
Last Investment Activity: May 16, 2024
Founded Date: Jun 2012
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@flatiron.com (100.0%)
-
Jason Harinstein
CFO
j*********n@flatiron.com
-
Dylan Meacham
Staff Software Engineering Tech Lead
d******m@flatiron.com
-
Bruce Gottlieb
Chief Operating Officer
b*******b@flatiron.com
-
Niloy Mukherjee
Founding Member- Product Mastermind Network
n********e@flatiron.com
-
General Inquiries
info@flatiron.com

HQ: Dublin, Dublin, Ireland
Alkermes is a biotechnology company that develops,Show more... manufactures and commercializes medicines for the treatment of chronic diseases.
HQ: Dublin, Dublin, Ireland
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Aug 22, 2024
Founded Date: 1987
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ALKS
Operating Status: Active
Main email format: sarah.smith@alkermes.com (100.0%)

HQ: Woodcliff Lake, New Jersey, United States
Eagle Pharmaceuticals is a company focused on deveShow more...loping and commercializing injectable products in the critical care and oncology areas.
HQ: Woodcliff Lake, New Jersey, United States
Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Pharmaceuticals
Business Type: Public
Employees: 101-250
Rounds: Venture - Series Unknown
Last Investment Activity: May 22, 2024
Founded Date: 2007
Company Type: For Profit
Stock Symbol: NASDAQ:EGRX
Operating Status: Active
Main email format: ssmith@eagleus.com (100.0%)
-
Jorma Lalla
Vice President
j****a@eagleus.com
-
Daniel Maher
d****r@eagleus.com
-
General Inquiries
info@eagleus.com
-
Unclassified inbox
aelgohail@eagleus.com
-
Unclassified inbox
jlarocca@eagleus.com
-
Unclassified inbox
egrx@openboard.info

HQ: South San Francisco, California, United States
Cytokinetics is a biopharmaceutical company develoShow more...ping therapies for debilitating diseases.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Debt
Last Investment Activity: Mar 15, 2024
Founded Date: 1998
Company Type: For Profit
Stock Symbol: NASDAQ:CYTK
Operating Status: Active
Main email format: ssmith@cytokinetics.com (100.0%)
-
Tina Controy
t******y@cytokinetics.com
-
General Inquiries
info@cytokinetics.com
-
Investor Relations
investor@cytokinetics.com
-
Legal Department
legal@cytokinetics.com
-
Unclassified inbox
medicalaffairs@cytokinetics.com

HQ: Clearwater, Florida, United States
SCC Soft Computer supplies laboratory and clinicalShow more... information systems for the healthcare industry.
HQ: Clearwater, Florida, United States
Specialized In: Biotechnology, Technology & Software, Healthcare & Medical
Business Type: Private
Employees: 1001-5000
Last Investment Activity: May 26, 2022
Founded Date: 1979
Company Type: For Profit
Operating Status: Active
Main email format: sarahs@softcomputer.com (60.0%)
-
Unclassified inbox
last_initial@softcomputer.com
-
Unclassified inbox
pr@softcomputer.com

HQ: Palo Alto, California, United States
BridgeBio focuses on the development and commerciaShow more...lization of precision medicines for various genetic diseases and cancers.
HQ: Palo Alto, California, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 2015
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:BBIO
Operating Status: Active
Main email format: ssmith@bridgebio.com (80.0%)
-
Neil Kumar
Co-Founder & CEO
n********r@bridgebio.com
-
Brian Stephenson
b*********n@bridgebio.com
-
General Inquiries
info@bridgebio.com
-
Customer Service
support@bridgebio.com
-
Management Department
manager@bridgebio.com
-
General Inquiries
contact@bridgebio.com
-
Sales Department
sales@bridgebio.com

HQ: Männedorf, Zurich, Switzerland
Tecan is a global provider of automated laboratoryShow more... instruments and solutions.
HQ: Männedorf, Zurich, Switzerland
Specialized In: Biotechnology
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Jun 26, 2024
Founded Date: 1980
Number of Exits: 1
Company Type: For Profit
Stock Symbol: SWX:TECN
Operating Status: Active
Main email format: sarah.smith@tecan.com (100.0%)
-
Guenter Weisshaar
g***************r@tecan.com
-
General Inquiries
info@tecan.com
-
Unclassified inbox
info-sg@tecan.com
-
Unclassified inbox
Judith.Stieff@tecan.com
-
Unclassified inbox
gretchen.williams@tecan.com

HQ: Morrisville, North Carolina, United States
Syneos Health, the only fully integrated end-to-enShow more...d clinical and commercial solution organization.
HQ: Morrisville, North Carolina, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Secondary
Last Investment Activity: Jan 12, 2024
Founded Date: 1985
Company Type: For Profit
Stock Symbol: NASDAQ:SYNH
Operating Status: Active
Main email format: sarah.smith@syneoshealth.com (100.0%)
-
Ian Dorrian
President Communications Europe
i*********n@syneoshealth.com
-
Agnieszka Mazek
International Corporate Recruiter II
a*************k@syneoshealth.com
-
Career Opportunities
jobs@syneoshealth.com
-
Unclassified inbox
abcdefghij@syneoshealth.com
-
Unclassified inbox
toby.marshall@syneoshealth.com

HQ: Exton, Pennsylvania, United States
West Pharmaceutical Services is a manufacturer of Show more...technologically advanced containment and delivery systems for injectable medicines.
HQ: Exton, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Last Investment Activity: Jun 21, 2024
Founded Date: 1923
Company Type: For Profit
Stock Symbol: NYSE:WST
Operating Status: Active
Main email format: sarah.smith@westpharma.com (100.0%)
-
Atul Patel
Vice President, Devices & Delivery Systems
a********l@westpharma.com
-
Preety Lall
p*********l@westpharma.com
-
Unclassified inbox
John.Sweeney@westpharma.com
-
Unclassified inbox
lynn.lundy@westpharma.com
-
Unclassified inbox
Kimberly.MacKay@westpharma.com
-
Customer Service
westpharmaceuticalservices@westpharma.com

HQ: South San Francisco, California, United States
Theravance Biopharma is a biopharmaceutical companShow more...y with one approved product.
HQ: South San Francisco, California, United States
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 251-500
Rounds: Post-IPO Equity
Last Investment Activity: Jan 16, 2024
Founded Date: 1996
Company Type: For Profit
Stock Symbol: NASDAQ:TBPH
Operating Status: Active
Main email format: ssmith@theravance.com (100.0%)
-
Christopher Porter
Vice President, Development Strategy and Innovation
c*****r@theravance.com
-
Jesse Fecker
Senior Director, Chief US Patent Counsel
j*****r@theravance.com
-
General Inquiries
medinfo@theravance.com
-
General Press Inquiries
cypress@theravance.com
-
Investor Relations
investor.relations@theravance.com

HQ: Cincinnati, Ohio, United States
Medpace, Inc., a clinical research organization, pShow more...rovides clinical development services for pharmaceutical and biotechnology
HQ: Cincinnati, Ohio, United States
Specialized In: Biotechnology, Pharmaceuticals
Acquired by: Cinven
Business Type: Public
Employees: 1001-5000
Last Investment Activity: Aug 12, 2024
Founded Date: 1992
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MEDP
Operating Status: Active
Main email format: s.smith@medpace.com (100.0%)

HQ: Venlo, Limburg, The Netherlands
QIAGEN provides technologies and products for preaShow more...nalytical sample preparation and linked molecular assay solutions.
HQ: Venlo, Limburg, The Netherlands
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics
Business Type: Public
Employees: 1001-5000
Rounds: Grant
Last Investment Activity: Mar 25, 2024
Founded Date: 1986
Number of Exits: 6
Company Type: For Profit
Stock Symbol: NYSE:QGEN
Operating Status: Active
Main email format: sarah.smith@qiagen.com (100.0%)

HQ: Holzminden, Niedersachsen, Germany
Symrise is a global supplier of fragrances, flavorShow more...ings, cosmetic active ingredients, raw materials and functional ingredients.
HQ: Holzminden, Niedersachsen, Germany
Specialized In: Biotechnology, Manufacturing & Industrial
Business Type: Public
Employees: 10001+
Last Investment Activity: Aug 1, 2024
Founded Date: 1874
Company Type: For Profit
Stock Symbol: ETR:SY1
Operating Status: Active
Main email format: sarah.smith@symrise.com (100.0%)

HQ: Fort Myers, Florida, United States
NeoGenomics is a cancer reference laboratory that Show more...provides cancer testing and partnership programs to pathologists and oncologists.
HQ: Fort Myers, Florida, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: Oct 29, 1998
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:NEO
Operating Status: Active
Main email format: ssmith@neogenomics.com (100.0%)
-
Unclassified inbox
aimee.bui@neogenomics.com
-
Human Resources Team
HR@neogenomics.com
-
Human Resources Team
hr@neogenomics.com

HQ: Suzhou, Jiangsu, China
Ascentage is a clinical-stage biopharmaceutical coShow more...mpany that develops drugs for the treatment of cancer.
HQ: Suzhou, Jiangsu, China
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Private
Employees: 101-250
Rounds: Series C
Last Investment Activity: Jan 2, 2024
Founded Date: 2009
Company Type: For Profit
Operating Status: Active
Main email format: ssmith@ascentagepharma.com (66.7%)
-
Unclassified inbox
PR@ascentagepharma.com
-
Unclassified inbox
bd@ascentagepharma.com
-
Unclassified inbox
cyang@ascentagepharma.com

HQ: Indianapolis, Indiana, United States
NICO develops medical devices for minimally invasiShow more...ve neurosurgery, as well as skull base and spinal surgical procedures.
HQ: Indianapolis, Indiana, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices
Business Type: Private
Employees: 1-10
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 1, 2024
Founded Date: 2007
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@niconeuro.com (100.0%)
-
Jim Pearson
Chief Executive Officer and President
j*********n@niconeuro.com
-
Shawna Dyachuk
v************k@niconeuro.com
-
James Baumgardt
t**************t@niconeuro.com
-
General Inquiries
info@niconeuro.com
-
Admin Team
admin@niconeuro.com
-
Sales Department
sales@niconeuro.com

HQ: Des Moines, Iowa, United States
Kemin Industries provides health-related products Show more...to improve the quality, safety, and efficacy of food.
HQ: Des Moines, Iowa, United States
Specialized In: Biotechnology, Food Delivery
Business Type: Private
Employees: 1001-5000
Rounds: Debt Financing
Last Investment Activity: Jan 15, 2024
Founded Date: 1961
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@kemin.com (100.0%)
-
Adriano Di Toppa
Enterprise Data Manager
a*****o@kemin.com
-
General Inquiries
info@kemin.com

HQ: Malvern, Pennsylvania, United States
Par Pharmaceutical develops, manufactures, and marShow more...kets innovative and cost-effective generic pharmaceutical products.
HQ: Malvern, Pennsylvania, United States
Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Jun 28, 2019
Founded Date: 1978
Number of Exits: 2
Company Type: For Profit
Operating Status: Active
Main email format: sarah.smith@parpharm.com (66.7%)
-
Unclassified inbox
cs.formulations@parpharm.com
-
Unclassified inbox
Thomas.Haughey@parpharm.com
-
Unclassified inbox
john.smith@parpharm.com

HQ: Osaka-shi, Osaka, Japan
Shionogi is a pharmaceutical company that offers pShow more...harmaceuticals, diagnostic reagents, and medical devices.
HQ: Osaka-shi, Osaka, Japan
Specialized In: Biotechnology, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Feb 27, 2024
Founded Date: Mar 17, 1878
Number of Exits: 3
Company Type: For Profit
Stock Symbol: TYO:4507
Operating Status: Active
Main email format: ssmith@shionogi.com (100.0%)
-
Sol Yates
s****s@shionogi.com
-
Unclassified inbox
ShionogiCommunications@shionogi.com
-
General Inquiries
contact@shionogi.eu
-
General Inquiries
info@shionogi.co.jp

HQ: Hamburg, Hamburg, Germany
Evotec is a pharmaceutical and life science companShow more...y that provides drug discovery and gene therapy solutions.
HQ: Hamburg, Hamburg, Germany
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics
Business Type: Public
Employees: 5001-10000
Rounds: Grant
Last Investment Activity: Mar 28, 2024
Founded Date: 1993
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:EVO
Operating Status: Active
Main email format: sarah.smith@evotec.com (75.0%)
-
Benedict Chen
Vice President
b***********n@evotec.com
-
General Inquiries
info@evotec.com

HQ: Boston, Massachusetts, United States
Haemonetics is a provider of blood and plasma suppShow more...lies and services.
HQ: Boston, Massachusetts, United States
Specialized In: Biotechnology, Coaching & Consulting, Healthcare & Medical, Medical Devices
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 18, 2024
Founded Date: 1971
Company Type: For Profit
Stock Symbol: NYSE:HAE
Operating Status: Active
Main email format: ssmith@haemonetics.com (75.0%)
-
Michelle Basil
Executive Vice President, General Counsel
m************l@haemonetics.com
-
Admin Team
admin@haemonetics.com
-
Sales Department
sales@haemonetics.com
-
Legal Department
legal@haemonetics.com
-
Unclassified inbox
CustomerServiceNA@Haemonetics.com

HQ: South San Francisco, California, United States
Genentech specializes in genetic testing and persoShow more...nalized medicine.
HQ: South San Francisco, California, United States
Specialized In: Biotechnology, Manufacturing & Industrial
Acquired by: Roche
Business Type: Delisted
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: Aug 30, 2024
Founded Date: Jan 1, 1976
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NYSE:DNA
Operating Status: Active
Main email format: sarahs@gene.com (100.0%)
-
Gig Codiga
g**c@gene.com
-
Jessica Russell Colantonio
c****************a@gene.com
-
Kevin Sharp
President/CEO
s*********n@gene.com
-
Lara Collazo
c******1@gene.com
-
Unclassified inbox
doej@gene.com
-
Unclassified inbox
chen.tao@gene.com
-
Unclassified inbox
carlsson.fredric@gene.com

HQ: Wilmington, Delaware, United States
Incyte is a drug discovery and development companyShow more... which hopes to build a proprietary product pipeline of novel small molecule drugs.
HQ: Wilmington, Delaware, United States
Specialized In: Biotechnology, Healthcare & Medical, Medical Devices, Pharmaceuticals
Business Type: Public
Employees: 501-1000
Last Investment Activity: Aug 16, 2024
Founded Date: 1991
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:INCY
Operating Status: Active
Main email format: ssmith@incyte.com (100.0%)
-
John Janik
Vice President Clinical Research
j****k@incyte.com
-
Abdelhak AMARA KORBA
a****a@incyte.com
-
Allison Kozeny
a*****y@incyte.com
-
Nicola Stephens
Sales Representative
n*******s@incyte.com
-
General Inquiries
medinfo@incyte.com
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.